RESORTTRUST,INC.(4681) News

Notice Regarding Changes in Representative Directors (Modification of Delegated Duties)

CONSOLIDATED FINANCIAL SUMMARY 3Q FY 2025 (from April 1, 2025 to December 31, 2025)

Financial results Presentation For 9-month Period Ended December 31, 2025

RESORTTRUST, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 24%, Oct-Dec Ordinary Profit Decreases by 49%

RESORTTRUST, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 5%, Raises Record High Profit Forecast, Dividend Revised Upward by 2 Yen

Notice of Revision of the Financial Results Forecast,Payment of a Dividend of Surplus (Interim Dividend), and Revision of the Dividend Forecast

Financial results Presentation For 6-month Period Ended September 30, 2025

Notice Concerning Disposal of Treasury Shares Through Third-party Allotment Associated with Additional Contribution to the BBT and the J-ESOP

CONSOLIDATED FINANCIAL SUMMARY 2Q FY 2025 (from April, 2025 to September, 2025)

Aiming to Achieve “zero-level prevention” that eliminate the causes of cause of disease Launch of Sales for “HIMEDIC Yokohama Bay Course”

Announcement Concerning the Presentation of Results from the Domestic Phase 2 Clinical Trial at ESMO Congress 2025

Announcement of Completion of the Specified Clinical Research of BNCT for Recurrent Breast Cancer, with the Cooperation of CICS

CONSOLIDATED FINANCIAL SUMMARY 1Q FY 2025 (from April 1, 2025 to June 30, 2025)

Financial results Presentation For 3-month Period Ended June 30, 2025

RESORTTRUST, Apr-Jun (1Q) Ordinary Profit Increases by 11%

CICS, Inc. has achieved the primary endpoint in a domestic phase2 clinical trial of BNCT for the treatment of angiosarcoma

Notice Concerning Completion of Allotment of Treasury Shares Disposed as Restricted Share Compensation

Corporate Governance Report

Corporate Governance Report

Corporate Governance Report